Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Food Archives
Print | Email | Share | Comments (0)

Eli Lilly, Amylin to Collaborate on Potential Diabetes Treatment


Dec 1, 2002

Investment for Development of a New Type 2 Drug

Eli Lilly and Company of Indianapolis, Indiana, and Amylin Pharmaceuticals of San Diego, California, have formed a global agreement to collaborate on development and sale of a potential new treatment for type 2 diabetes.

The treatment, now in phase 3 clinical trials, is called AC2993, a peptide that has been shown to stimulate insulin secretion when blood glucose concentrations are high, but not when blood glucose levels are low, according to information from Amylin.

Under the terms of the agreement, Lilly will make an initial nonrefundable investment of $80 million; will purchase $30 million of Amylin common stock at a price of $18.69 per share; and will, in the future, pay Amylin up to $85 million at certain milestones in the development of the product. Lilly also will pay up to $130 million contingent on global sales of the product.

For a limited time before the potential sale of AC2993, Amylin will co-promote Humatrope, Lilly's recombinant human growth hormone, in the United States.

A submission to the U.S. Food and Drug Administration for AC2993 is expected as early as 2004.


Categories: Blood Glucose, Diabetes, Diabetes, Food, Insulin, Medications Research, Type 2 Issues



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Dec 1, 2002

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.